Jianya Biotechnology Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 189

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

Jianya Biotechnology General Information

Description

Manufacturer of pharmaceutical products intended to treat medical conditions. The company's technology utilizes drug delivery systems and controlled-release formulations, enabling healthcare providers to access specialty generics, modified new drugs, injectable medications, central nervous system drugs, and pediatric medicines for the treatment of diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Number 1, Gongye 1st Road
  • Hukou Township
  • Hsin-Chu, Hsinchu 300-36
  • Taiwan
+886 03
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Drug Delivery
Parent Company
Vertical(s)
Former Stock Listing
4130
Corporate Office
  • Number 1, Gongye 1st Road
  • Hukou Township
  • Hsin-Chu, Hsinchu 300-36
  • Taiwan
+886 03

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jianya Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Jianya Biotechnology‘s full profile, request access.

Request a free trial

Jianya Biotechnology Patents

Jianya Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240238272-A1 Treatment of antiphospholipid syndrome using s-hydroxychloroquine Pending 04-Jun-2021
WO-2022256426-A1 Treatment of antiphospholipid syndrome using s-hydroxychloroquine Inactive 04-Jun-2021
EP-3915562-A1 Treatment of lupus erythematosus using s- hydroxychloroquine Inactive 31-May-2020
US-20210369699-A1 Treatment of lupus erythematosus using s-hydroxychloroquine Inactive 31-May-2020
JP-2021187831-A Treatment of lupus erythematosus with s-hydroxychloroquine Pending 31-May-2020 A61K31/4706
To view Jianya Biotechnology’s complete patent history, request access »

Jianya Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jianya Biotechnology Investments (1)

Jianya Biotechnology’s most recent deal was a Later Stage VC with NaviFUS. The deal was made on 15-Mar-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NaviFUS 15-Mar-2021 Later Stage VC Therapeutic Devices
To view Jianya Biotechnology’s complete investments history, request access »

Jianya Biotechnology FAQs

  • When was Jianya Biotechnology founded?

    Jianya Biotechnology was founded in 1993.

  • Where is Jianya Biotechnology headquartered?

    Jianya Biotechnology is headquartered in Hsin-Chu, Taiwan.

  • What is the size of Jianya Biotechnology?

    Jianya Biotechnology has 189 total employees.

  • What industry is Jianya Biotechnology in?

    Jianya Biotechnology’s primary industry is Pharmaceuticals.

  • Is Jianya Biotechnology a private or public company?

    Jianya Biotechnology is a Private company.

  • What is the current valuation of Jianya Biotechnology?

    The current valuation of Jianya Biotechnology is .

  • What is Jianya Biotechnology’s current revenue?

    The current revenue for Jianya Biotechnology is .

  • How much funding has Jianya Biotechnology raised over time?

    Jianya Biotechnology has raised $27.2M.

  • When was Jianya Biotechnology acquired?

    Jianya Biotechnology was acquired on 28-Jul-2026.

  • Who acquired Jianya Biotechnology?

    Jianya Biotechnology was acquired by Easywell Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process